{
    "nct_id": "NCT04761770",
    "official_title": "Phase II Study of a Geriatric Assessment-Driven, Risk-Adapted Allogeneic Hematopoietic Cell Transplant Strategy for Older Patients With Myeloid Malignancies",
    "inclusion_criteria": "* are 60 years or older\n* have a pathologically confirmed myeloid malignancies including acute myeloid leukemia, ,myelodysplastic syndrome, myeloproliferative neoplasms, or related blood disorders including chronic myelomonocytic leukemia, atypical chronic myeloid leukemia, and myelodysplastic/myeloproliferative overlapping syndrome\n* have <10% blasts in bone marrow prior to transplant\n* have a matched related or unrelated donor, mismatched unrelated donor, or haploidentical donor\n* Meet institutional standard criteria for allogeneic transplantation as determined by the primary transplant physician\n* Undergoes transplantation using the allocated conditioning regimen intensity defined by the protocol-specified criteria below:\n\n  * HCT-CI/Age <5 and IADL normal = myeloablative regimen\n  * HCT-CI/Age ≥5 and/or IADL impairment = RIC/NMA regimen\nHealthy volunteers allowed\nMust have minimum age of 60 Years",
    "exclusion_criteria": "* Prior hematopoietic cell transplantation\n* Cord blood donors\n* Persons with active, refractory disease defined by ≥10% blasts in bone marrow prior to transplant",
    "miscellaneous_criteria": ""
}